List of Tables
Table 1. Gastrointestinal Disorder Therapeutics Market Trends
Table 2. Gastrointestinal Disorder Therapeutics Market Drivers & Opportunity
Table 3. Gastrointestinal Disorder Therapeutics Market Challenges
Table 4. Gastrointestinal Disorder Therapeutics Market Restraints
Table 5. Global Gastrointestinal Disorder Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Gastrointestinal Disorder Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Gastrointestinal Disorder Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Gastrointestinal Disorder Therapeutics
Table 10. Global Gastrointestinal Disorder Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Disorder Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Gastrointestinal Disorder Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Gastrointestinal Disorder Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Gastrointestinal Disorder Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Gastrointestinal Disorder Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Gastrointestinal Disorder Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Gastrointestinal Disorder Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gastrointestinal Disorder Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Gastrointestinal Disorder Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Gastrointestinal Disorder Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Gastrointestinal Disorder Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Gastrointestinal Disorder Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Gastrointestinal Disorder Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Gastrointestinal Disorder Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Gastrointestinal Disorder Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Gastrointestinal Disorder Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Gastrointestinal Disorder Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Gastrointestinal Disorder Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Gastrointestinal Disorder Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. AstraZeneca Basic Information List
Table 32. AstraZeneca Description and Business Overview
Table 33. AstraZeneca Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of AstraZeneca (2019-2024)
Table 35. AstraZeneca Recent Developments
Table 36. Takeda Pharmaceutical Basic Information List
Table 37. Takeda Pharmaceutical Description and Business Overview
Table 38. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Takeda Pharmaceutical (2019-2024)
Table 40. Takeda Pharmaceutical Recent Developments
Table 41. Johnson & Johnson Basic Information List
Table 42. Johnson & Johnson Description and Business Overview
Table 43. Johnson & Johnson Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Johnson & Johnson (2019-2024)
Table 45. Johnson & Johnson Recent Developments
Table 46. Eisai Basic Information List
Table 47. Eisai Description and Business Overview
Table 48. Eisai Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Eisai (2019-2024)
Table 50. Eisai Recent Developments
Table 51. Abbott Laboratories Basic Information List
Table 52. Abbott Laboratories Description and Business Overview
Table 53. Abbott Laboratories Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Abbott Laboratories (2019-2024)
Table 55. Abbott Laboratories Recent Developments
Table 56. Salix Pharmaceuticals Basic Information List
Table 57. Salix Pharmaceuticals Description and Business Overview
Table 58. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Salix Pharmaceuticals (2019-2024)
Table 60. Salix Pharmaceuticals Recent Developments
Table 61. Bausch Health Basic Information List
Table 62. Bausch Health Description and Business Overview
Table 63. Bausch Health Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Bausch Health (2019-2024)
Table 65. Bausch Health Recent Developments
Table 66. Allergan Basic Information List
Table 67. Allergan Description and Business Overview
Table 68. Allergan Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Allergan (2019-2024)
Table 70. Allergan Recent Developments
Table 71. Bayer Basic Information List
Table 72. Bayer Description and Business Overview
Table 73. Bayer Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Bayer (2019-2024)
Table 75. Bayer Recent Developments
Table 76. UCB Basic Information List
Table 77. UCB Description and Business Overview
Table 78. UCB Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of UCB (2019-2024)
Table 80. UCB Recent Developments
Table 81. AbbVie Basic Information List
Table 82. AbbVie Description and Business Overview
Table 83. AbbVie Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of AbbVie (2019-2024)
Table 85. AbbVie Recent Developments
Table 86. GlaxoSmithKline Basic Information List
Table 87. GlaxoSmithKline Description and Business Overview
Table 88. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of GlaxoSmithKline (2019-2024)
Table 90. GlaxoSmithKline Recent Developments
Table 91. Astellas Pharma Basic Information List
Table 92. Astellas Pharma Description and Business Overview
Table 93. Astellas Pharma Gastrointestinal Disorder Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Gastrointestinal Disorder Therapeutics Business of Astellas Pharma (2019-2024)
Table 95. Astellas Pharma Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Gastrointestinal Disorder Therapeutics Downstream Customers
Table 99. Gastrointestinal Disorder Therapeutics Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Gastrointestinal Disorder Therapeutics Product Picture
Figure 2. Global Gastrointestinal Disorder Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gastrointestinal Disorder Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Gastrointestinal Disorder Therapeutics Report Years Considered
Figure 5. Global Gastrointestinal Disorder Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastrointestinal Disorder Therapeutics Revenue in 2023
Figure 7. Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Irritable Bowel Syndrome (IBS) Picture
Figure 9. Chronic Constipation (CC) Picture
Figure 10. Ulcerative Colitis (UC) Picture
Figure 11. Global Gastrointestinal Disorder Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Gastrointestinal Disorder Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Clinics
Figure 15. Product Picture of Others
Figure 16. Global Gastrointestinal Disorder Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Gastrointestinal Disorder Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Gastrointestinal Disorder Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Gastrointestinal Disorder Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Gastrointestinal Disorder Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Gastrointestinal Disorder Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Gastrointestinal Disorder Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Gastrointestinal Disorder Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Gastrointestinal Disorder Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Gastrointestinal Disorder Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Gastrointestinal Disorder Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Gastrointestinal Disorder Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Gastrointestinal Disorder Therapeutics Sales Value (%), (2019-2030)
Figure 29. United States Gastrointestinal Disorder Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Gastrointestinal Disorder Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Gastrointestinal Disorder Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Gastrointestinal Disorder Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Gastrointestinal Disorder Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Gastrointestinal Disorder Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 35. China Gastrointestinal Disorder Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Gastrointestinal Disorder Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 37. China Gastrointestinal Disorder Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Gastrointestinal Disorder Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Gastrointestinal Disorder Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Gastrointestinal Disorder Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Gastrointestinal Disorder Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Gastrointestinal Disorder Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Gastrointestinal Disorder Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Gastrointestinal Disorder Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Gastrointestinal Disorder Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Gastrointestinal Disorder Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 47. India Gastrointestinal Disorder Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Gastrointestinal Disorder Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 49. India Gastrointestinal Disorder Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 50. Gastrointestinal Disorder Therapeutics Industrial Chain
Figure 51. Gastrointestinal Disorder Therapeutics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
